View Clinical Trial (Medical Research Study)
Safety of Riluzole in Patients With Acute Spinal Cord Injury - NCT00876889-19107(Clinical Trial 282615)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
19107 |
| Conditions: |
|
Spinal Cord Injury |
| Purpose: |
|
The purpose of the study is to find out if the use of the drug Riluzole is both safe and
improves outcome in patients with acute traumatic spinal cord injury (SCI).
|
| Study summary: |
|
The primary aim of the study is to develop acute care safety and pharmacokinetic profiles of
riluzole in patients who have sustained a acute traumatic spinal cord injury. Secondary
objectives are to conduct exploratory analyses of functional outcomes for purposes of
planning a subsequent Phase II randomized study of the efficiency of Riluzole for the
treatment of acute traumatic spinal cord injury. |
| Criteria: |
|
Inclusion Criteria:
- Age equal to or greater than 18 years and less than or equal to 70 years;
- Willing to give written informed consent to participate in the study. The informed
consent may require legally authorized representative to sign if arm/hand function is
compromised.
- No other life-threatening injury
- Spinal cord injury at the neurologic level from C4 to T12
- ASIA Impairment Scale level A, B or C
- No cognitive impairment which would preclude an informed consent (including moderate
or severe traumatic brain injury)
- Less than 12 hours since injury
Exclusion Criteria:
- Equal or more than 12 hours since injury
- Hypersensitivity to riluzole or any of its components
- Unable to receive riluzole orally or via NG tube
- History of liver or kidney disease (e.g. Hepatitis A, B or C, Cirrhosis, etc.)
- Has a recent history of regular substance abuse (illicit drugs, alcohol)
- Unconscious
- Penetrating spinal cord injury
- Pregnancy as established by urine pregnancy test
- Breastfeeding
- Life expectancy less than 12 months
- Is currently involved in another therapeutic SCI research study that precludes or
complicates participation in this study (e.g. study of another therapeutic drug
aiming for spinal cord injury recovery, any study that substantially interferes with
the follow -up schedule (f/u) schedule, or any high risk study that complicates
evaluation of safety outcomes. Types of studies that would not preclude participation
are e.g. behavioral adaptation studies, mental health interventions)
- Has a mental disorder or other illness, which in the view of the site investigator,
would preclude accurate evaluation (e.g. schizophrenia, severe cognitive disability,
Parkinson disease)
- Unable to commit to the follow-up schedule
- Is a prisoner
- Unable to converse, read or write English at the elementary school level |
|
|
|
| Study is available at: |
|
Thomas Jefferson University
Philadelphia, PA 19107
United States
Primary Contact:
Amanda Salvatore, RN
Email: Amanda.salvatore@jefferson.edu
Phone: 215-503-5739
Secondary Contact:
Elizabeth Toups, MSN, CCRP
Email: etoups@tmhs.org
Phone: 713-441-3897 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|